NEW YORK, Oct. 4 /PRNewswire/ -- HealthShares(TM) Inc., an investment company with a series of 20 underlying fund portfolios, today announced it has been informed by Standard & Poor's, the calculating agent for the HealthShares(TM) Cardio Devices Index, that effective at the opening of trading on October 8, 2007, Intuitive Surgical Inc.(NasdaqGS: ISRG) will replace Foxhollow Technologies Inc. (NasdaqGS: FOXH) in the HealthShares(TM) Cardio Devices Index.
About HealthShares(TM)
XShares Advisors LLC, a financial services company based in New York, is the creator of the HealthShares(TM) family of Exchange-Traded Funds (ETFs). HealthShares(TM) ETFs are organized into therapeutic 'Verticals' and represent specific areas of the healthcare, life science and biotechnology industries. Each Vertical addresses a distinct sub-segment of healthcare, such as the diagnosis and treatment of specific therapeutic areas (e.g. cardiology, cancer, infectious disease, etc.) and the development of medical devices (e.g. orthopedic repair, cardio devices, etc.). Each ETF tracks an index of 22-25 stocks and offers institutional and individual investors a more precise financial instrument that leverages the potential of healthcare investing while mitigating the risks of single stock picking. For more information, visit the company's website at: http://www.healthsharesinc.com.
About XShares
XShares Advisors LLC, a subsidiary of XShares Group LLC, is a
registered investment advisor that provides investment advisory services to
Exchange-Traded Funds. XShares also partners with major institutions and
index providers seeking to bring innovative Exchange-Traded Funds to market
using its administrative platform. In addition, XShares creates and
licenses distinctive intellectual property for its ETFs, developing
products that allow for innovative trading strategies and alternative
investments for the financial c
'/>"/>
| SOURCE HealthShares Inc. Copyright©2007 PR Newswire. All rights reserved |